FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk
Major pharmacies had already pulled the popular heartburn drug and its generic equivalents due to a contaminant. Now the Food and Drug Administration says definitively they should not be sold or used.
About six months after several major pharmacies pulled Zantac and its generic equivalents off their shelves, citing a potentially harmful contaminant in the heartburn medication, federal regulators are throwing their weight behind the drug's removal from the market. The Food and Drug that manufacturers immediately pull all prescription and over-the-counter versions of the drug.
